메뉴 건너뛰기
Inflammatory Bowel Diseases
Volumn 12, Issue 11, 2006, Pages 1089-1090
Infliximab single administration followed by acute liver injury [2]
Author keywords

[No Author keywords available]
Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; INFLIXIMAB; MESALAZINE; STEROID;
EID: 33750529146     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.mib.0000246783.75753.9f     Document Type: Letter
Times cited : (14)
References (8)
  • 1
    • 4344614501 scopus 로고    scopus 로고
    • Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: Need for primary prophylaxis
    • Esteve M, Saro C, Gonzalez-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut. 2004;53:1363-1365.
    • (2004) Gut , vol.53 , pp. 1363-1365
    • Esteve, M.1    Saro, C.2    Gonzalez-Huix, F.3
  • 2
    • 0034893164 scopus 로고    scopus 로고
    • Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: Comment on the article by Charles et al
    • Saleem G, Li SC, MacPherson BR, et al. Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al. Arthritis Rheum. 2001;44:1966-1968.
    • (2001) Arthritis Rheum , vol.44 , pp. 1966-1968
    • Saleem, G.1    Li, S.C.2    MacPherson, B.R.3
  • 3
    • 33750328041 scopus 로고    scopus 로고
    • Serious liver disease induced by infliximab
    • March 18, Epub ahead of print
    • Tobon GJ, Cañas C, Jaller JJ, et al. Serious liver disease induced by infliximab. Clin Rheumatol. March 18, 2006. Epub ahead of print.
    • (2006) Clin Rheumatol
    • Tobon, G.J.1    Cañas, C.2    Jaller, J.J.3
  • 4
    • 33750375808 scopus 로고    scopus 로고
    • Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
    • March 21, Epub ahead of print
    • Garcia Aparicio AM, Rey JR, Sanz AH, et al. Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol. March 21, 2006. Epub ahead of print.
    • (2006) Clin Rheumatol
    • Garcia Aparicio, A.M.1    Rey, J.R.2    Sanz, A.H.3
  • 5
    • 0035160406 scopus 로고    scopus 로고
    • Infliximab-associated reversible cholestatic liver disease
    • Menghini VV, Arora AS. Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc. 2001;76:84-86.
    • (2001) Mayo Clin Proc , vol.76 , pp. 84-86
    • Menghini, V.V.1    Arora, A.S.2
  • 6
    • 0029028492 scopus 로고
    • Changes of liver-resident NK cells during liver regeneration in rats
    • Polimeno L, Azzarone A, Francavilla A, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol. 1995;154:6324-6338.
    • (1995) J Immunol , vol.154 , pp. 6324-6338
    • Polimeno, L.1    Azzarone, A.2    Francavilla, A.3
  • 7
    • 0023626505 scopus 로고
    • Criteria of imputation of acute hepatitis to a drug: Results of consensus meetings
    • Danan G, Benichou C, Begaud B, et al. Criteria of imputation of acute hepatitis to a drug: results of consensus meetings. Gastroenterol Clin Biol. 1987;11:581-585.
    • (1987) Gastroenterol Clin Biol , vol.11 , pp. 581-585
    • Danan, G.1    Benichou, C.2    Begaud, B.3
  • 8
    • 85056677797 scopus 로고    scopus 로고
    • Regulatory perspectives
    • Kaplowitz N, DeLeve LD, eds. New York, NY: Marcel Dekker
    • Senior JR. Regulatory perspectives. In: Kaplowitz N, DeLeve LD, eds. Drug-Induced Liver Disease. New York, NY: Marcel Dekker; 2003:739-754.
    • (2003) Drug-Induced Liver Disease , pp. 739-754
    • Senior, J.R.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.